Zhao, Zi-Ming
Yost, Susan E.
Hutchinson, Katherine E.
Li, Sierra Min
Yuan, Yate-Ching
Noorbakhsh, Javad
Liu, Zheng
Warden, Charles
Johnson, Radia M.
Wu, Xiwei
Chuang, Jeffrey H.
Yuan, Yuan
Funding for this research was provided by:
Stop Cancer
NIH K-12 Career Development Award
National Institutes of Health (P30CA034196, R21CA191848, U24 CA224067)
Article History
Received: 17 September 2018
Accepted: 7 January 2019
First Online: 21 January 2019
Authors’ information
: Not applicable
: All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards. Informed consent was obtained from all participants included in the study. All tumor specimens were identified through a City of Hope IRB-approved retrospective protocol from patients consented to City of Hope Biorepository Protocol.
: Not applicable
: YY has contracted clinical trials and research projects sponsored by Merck, Eisai, NoSvartis, Genentech, and Pfizer. The other authors declare that they have no competing interests.
: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.